K. Swenerton
- Reproductive Medicine top 1%
- Oncology top 10%
- Molecular Biology
- Surgery
- Pathology and Forensic Medicine top 10%
- Co-authors
- Paul HoskinsAmit M. OzaG. OʼConnellGavin StuartMoni RoyJ. CarmichaelGrant D. MacLeanGarry V. Krepart
- Topics
- Ovarian cancer diagnosis and treatment (23 papers)Intraperitoneal and Appendiceal Malignancies (6 papers)Cancer Treatment and Pharmacology (6 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
K. Swenerton
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 73
- Reproductive Medicine 500
- Oncology 455
- Molecular Biology 367
- Surgery 255
- Pathology and Forensic Medicine 204
Countries citing papers authored by K. Swenerton
This map shows the geographic impact of K. Swenerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Swenerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Swenerton more than expected).
Fields of papers citing papers by K. Swenerton
This network shows the impact of papers produced by K. Swenerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Swenerton. The network helps show where K. Swenerton may publish in the future.
Co-authorship network of co-authors of K. Swenerton
This figure shows the co-authorship network connecting the top 25 collaborators of K. Swenerton. A scholar is included among the top collaborators of K. Swenerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Swenerton. K. Swenerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 51 | |
| 3 | 44 | |
| 4 | 1 | |
| 5 | 60 | |
| 6 | 33 | |
| 7 | 55 | |
| 8 | Long-term follow-up confirms a survival advantage of paclitaxel-cisplatin (CP) regimen over the cyclophosphamide-cisplatin (CP) combination in advanced ovarian cancer | 5 |
| 9 | 13 | |
| 10 | 4 | |
| 11 | 60 | |
| 12 | 51 | |
| 13 | 136 | |
| 14 | 27 | |
| 15 | 32 | |
| 16 | 10 | |
| 17 | 155 | |
| 18 | Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy. | 18 |
| 19 | High-dose-intensity regimen of weekly doxorubicin and cisplatin in the treatment of patients with stage III and IV epithelial ovarian carcinoma. | 3 |
| 20 | Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study. | 27 |
About K. Swenerton
K. Swenerton is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (23 papers), Intraperitoneal and Appendiceal Malignancies (6 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Reproductive Medicine (500 citations), Obstetrics and Gynecology (144 citations) and Oncology (455 citations). K. Swenerton has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Paul Hoskins, Amit M. Oza, G. OʼConnell, Gavin Stuart, Moni Roy, J. Carmichael, Grant D. MacLean, Garry V. Krepart, Pierre Drouin and David G. Huntsman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.